IL15 and cancer: In the 2008 summary of the National Cancer Institute Immunotherapy Agent Workshop titled “Twelve immunotherapy drugs that could cure cancers”, Mac Cheever wrote in his article that if tested creatively and in combination, immunotherapy regimens will be derived to benefit many cancer patients, and IL-15 was ranked as the most promising candidate.